New Science Ventures
Overview
New Science Ventures is a venture capital firm focused on investments in life sciences and information technology companies.
Investment Focus
- Companies employing novel scientific approaches
- Addressing significant unmet needs
- Targeting large, global markets (> $1 billion)
- Differentiated value propositions
- Strong management teams
Portfolio Companies
Reach New Science Ventures directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about New Science Ventures
What sectors does New Science Ventures invest in?
New Science Ventures invests in Industrial, Transportation, Artificial Intelligence, Life Sciences, Pharmaceuticals and Medical Devices, and is based in New York, United States. New Science Ventures is listed as a vc in the ConnectSafely investor database.
What stage does New Science Ventures invest at?
New Science Ventures backs companies at Early Stage and Growth.
Which regions does New Science Ventures invest in?
New Science Ventures invests across United States, United Kingdom, Europe, China and India.
Who are the partners at New Science Ventures?
Team members listed for New Science Ventures include Somu Subramaniam (Managing Partner) and Thomas Lavin (Partner).
What companies has New Science Ventures invested in?
New Science Ventures's portfolio includes Phase Four, Sagence AI, NorthSea Therapeutics, Ventyx Biosciences and Novadip Biosciences.
How do I contact New Science Ventures?
New Science Ventures's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
